scispace - formally typeset
Search or ask a question
Author

Yukiko Kusama

Bio: Yukiko Kusama is an academic researcher. The author has contributed to research in topics: Antibody & Autoimmune pancreatitis. The author has an hindex of 1, co-authored 2 publications receiving 1 citations.

Papers
More filters
Journal ArticleDOI
TL;DR: AC-IgG could replace IgG to count IgG+ cells because of its lower Cv, and the data showed that the results of both methods were largely consistent.
Abstract: Background.Immunoglobulin (Ig) G4-related diseases (RDs) are systemic diseases in which serum IgG4 levels are frequently elevated. They can cause diffuse or focal tumor formation, organ swelling, a...

1 citations

Journal ArticleDOI
22 Sep 2021-Amyloid
TL;DR: In this paper, the authors reported glucagon-derived localised amyloidosis associated with pancreatic neuroendocrine tumors (NETs) and reported another novicious case.
Abstract: Neuroendocrine tumours (NET) sometimes exhibit amyloid deposition [1]. Previously, we reported glucagon-derived localised amyloidosis associated with pancreatic NET [2]. Here, we report another nov...

1 citations


Cited by
More filters
Journal ArticleDOI
02 Oct 2022-Amyloid
TL;DR: The nomenclature principles remain unchanged but there is an ongoing discussion regarding the importance and varying nature of intracellular protein aggregates, particularly those associated with neurodegenerative diseases as mentioned in this paper .
Abstract: Abstract The Nomenclature Committee of the International Society of Amyloidosis met at the XVIII International Symposium on Amyloidosis in September and virtually in October 2022 with discussions resulting in this upgraded nomenclature recommendation. The nomenclature principles remain unchanged but there is an ongoing discussion regarding the importance and varying nature of intracellular protein aggregates, particularly those associated with neurodegenerative diseases. Six novel proteins were added to the list of human amyloid fibril proteins. Of these, three are polypeptide hormones and two currently utilised peptide drugs, making the number of known iatrogenic amyloid forms four, all appearing as subcutaneous nodules at the injection site. The sixth novel amyloid fibril protein is the transmembrane 106B protein, forming intracellular amyloid fibrils in disorders associated with frontotemporal dementia. The number of known human amyloid fibril proteins is now 42.

34 citations